Indian pharma companies have been struggling to maintain margins because of strong headwinds. Due to increased competition, pharma companies are experiencing price erosion in the market, resulting in sluggish growth. While price erosion is not the only issue at hand, China’s lockdown that caused supply chain disruption, the rise in raw material prices, and the Russia-Ukraine war have raised packaging costs.
Fed meeting outcome today: How it may impact Indian stock market
Federal Reserve’s decisions, especially on interest rates, have a profound impact on global markets, including India. Chair Jerome Powell, could chalk out a future trajectory,